Jason Comander, MD, PhD, performs the procedure to deliver the CRISPR-based medicine as part of the BRILLIANCE trial in September 2020 at Mass Eye and Ear. Disclaimer: AAAS and EurekAlert!
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback